Effect of the GLP-1 Receptor Agonist Lixisenatide on Counterregulatory Responses to Hypoglycemia in Subjects With Insulin-Treated Type 2 Diabetes
Article Information
vol. 39 no. 2 242-249
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 14, 2015
- Accepted September 27, 2015
- Published in print January 21, 2016.
- Published online ahead of print November 4, 2015.
Article Versions
- Previous version (November 4, 2015 - 07:22).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
Author Information
- Johan Farngren,
- Margaretha Persson and
- Bo Ahrén⇑
- Corresponding author: Bo Ahrén, bo.ahren{at}med.lu.se.
Statistics from Altmetric.com
Article usage
In this Issue
February 2016, 39(2)
Effect of the GLP-1 Receptor Agonist Lixisenatide on Counterregulatory Responses to Hypoglycemia in Subjects With Insulin-Treated Type 2 Diabetes
